Biogen Inc Cmn (BIIB) 314.81 $BIIB Stock Market News for

New Post Public Reply Private Reply Replies (0) Message Board

Sep 22, 2016 at 7:17 PM

Biogen Inc Cmn (BIIB) 314.81 $BIIB

Stock Market News for September 21, 2016
Zacks Equity Research - Zacks Investment Research - Wed Sep 21, 9:22AM CDT
Benchmarks finished slightly higher on Tuesday ahead of the two-day policy meetings of the Fed and Bank of Japan (BOJ) ending today
FDX: 173.66 (-0.20), AGN: 243.43 (+5.02), PBR: 9.56 (+0.05), BIIB: 314.81 (+2.81), SON: 53.50 (+0.46), GILD: 81.52 (-0.18), FB: 130.08 (+0.14), XOM: 83.54 (+0.24), AMGN: 175.62 (+1.77), KBH: 15.65 (+0.42), TBRA: 39.50 (+0.42)

Biotech Stock Roundup: Tobira Soars on Acquisition Deal, FDA Says Yes to Sarepta DMD Drug
Arpita Dutt - Zacks Investment Research - Wed Sep 21, 7:39AM CDT
The biotech sector got a boost with Allergan announcing its intention to acquire Tobira as well as a couple of other companies.
BIIB: 314.81 (+2.81), VRTX: 92.12 (+0.30), GERN: 2.22 (-0.03), SRPT: 60.97 (+4.75), TBRA: 39.50 (+0.42), ALKS: 51.00 (+0.52), REGN: 408.01 (+1.49)

Biogen Idec Has Returned 23.9% Since SmarTrend Recommendation (BIIB)
Comtex SmarTrend(R) - Tue Sep 20, 1:00PM CDT
SmarTrend identified an Uptrend for Biogen Idec (NASDAQ:BIIB) on July 7th, 2016 at $247.44. In approximately 3 months, Biogen Idec has returned 23.93% as of today's recent price of $306.65.
BIIB: 314.81 (+2.81)

Look for Shares of Biogen Idec to Potentially Pullback after Yesterday's 1.70% Rise
Comtex SmarTrend(R) - Tue Sep 20, 12:16PM CDT
Biogen Idec (NASDAQ:BIIB) traded in a range yesterday that spanned from a low of $304.00 to a high of $308.67. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $308.00 on volume of 552,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIIB: 314.81 (+2.81)

New Data Presented at ECTRIMS Reinforce Efficacy of ZINBRYTA(TM) (Daclizumab) and Support Long-Term Safety Profile
BusinessWire - Thu Sep 15, 6:30AM CDT
--Interim Analysis of EXTEND Study Shows Sustained ZINBRYTA Efficacy for Up to Five Years
BIIB: 314.81 (+2.81), ABBV: 65.08 (+0.98)

Biogen to Report Third Quarter 2016 Financial Results on October 26, 2016
BusinessWire - Wed Sep 14, 3:01PM CDT
Biogen Inc. (NASDAQ:BIIB) today announced it will report third quarter 2016 financial results on Wednesday, October 26, 2016, before the financial markets open.
BIIB: 314.81 (+2.81)

Biotech Stock Roundup: Horizon-Raptor Acquisition Deal, Geron Down on Pipeline News
Arpita Dutt - Zacks Investment Research - Wed Sep 14, 7:47AM CDT
With the Horizon-Raptor acquisition deal being announced, will the biotech sector see more such merger and acquisition announcements?
BIIB: 314.81 (+2.81), RPTP: 8.96 (-0.03), LXRX: 18.82 (-0.08), GILD: 81.52 (-0.18), GERN: 2.22 (-0.03), HZNP: 19.41 (+0.24), SPPI: 4.81 (+0.34)

New Data Affirm Strong Efficacy and Well-Characterized Safety Profile of TECFIDERA(R) in Both Clinical Studies and Real-World Setting
BusinessWire - Wed Sep 14, 6:30AM CDT
--a^' Benefit-Risk Profile of TECFIDERA Remains Favorable Up to Nine Years a^'
BIIB: 314.81 (+2.81)

Perrigo Up as Starboard Reveals Stake, Changes Proposed
Zacks Equity Research - Zacks Investment Research - Tue Sep 13, 3:30PM CDT
Perrigo's (PRGO) shares gained after the activist investor, Starboard, disclosed in a letter its 4.6% stake in the company, and prompted it to take immediate steps.
BIIB: 314.81 (+2.81), PRGO: 97.12 (+3.43), GERN: 2.22 (-0.03), MYL: 42.59 (+0.68)

Biotech Stocks Bounce Back in Monday Trading: 3 Picks
Zacks Equity Research - Zacks Investment Research - Tue Sep 13, 8:12AM CDT
Media and political focus on the high prices of drugs have made things difficult for the pharma/biotech sector since the past one year.
ABT: 42.22 (+0.30), BIIB: 314.81 (+2.81), VNDA: 16.62 (+1.06), PFE: 34.15 (-0.13), AMGN: 175.62 (+1.77), AEGR: 2.65 (+0.33), LLY: 81.29 (+0.42), PDLI: 3.35 (-0.01), JNJ: 119.46 (+0.55), GILD: 81.52 (-0.18), AZN: 34.28 (+0.53), MRK: 63.02 (+0.32), SNY: 38.57 (+0.19), NVS: 82.03 (+0.51)

Biogen Idec Shares Up 22.3% Since SmarTrend's Buy Recommendation (BIIB)
Comtex SmarTrend(R) - Tue Sep 13, 1:03AM CDT
SmarTrend identified an Uptrend for Biogen Idec (NASDAQ:BIIB) on July 7th, 2016 at $247.44. In approximately 2 months, Biogen Idec has returned 22.32% as of today's recent price of $302.66.
BIIB: 314.81 (+2.81)

Biogen Idec Set to Possibly Rebound After Yesterday's Selloff of 2.40%
Comtex SmarTrend(R) - Fri Sep 09, 12:59PM CDT
Biogen Idec (NASDAQ:BIIB) traded in a range yesterday that spanned from a low of $299.09 to a high of $305.48. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of $307.42 on volume of 870,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BIIB: 314.81 (+2.81)

Biogen Idec Falls 2.40% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Fri Sep 09, 12:57PM CDT
Biogen Idec (NASDAQ:BIIB) traded in a range yesterday that spanned from a low of $299.09 to a high of $305.48. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of $307.42 on volume of 870,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BIIB: 314.81 (+2.81)

Biogen Demonstrates Commitment to Improving Patient Outcomes with Study on Burden of MS and New Clinical Data from Its Leading MS Portfolio
BusinessWire - Thu Sep 08, 6:30AM CDT
--Comparative Effectiveness Studies Reinforce Clinical Data Supporting the Strong, Sustained Efficacy of TECFIDERA(R)
BIIB: 314.81 (+2.81), ACOR: 27.22 (+0.15)

These Stocks are Predicted to Outperform this Week According to Forcerank
ESTMZ - Wed Sep 07, 10:10AM CDT
Each week Forcerank runs a variety of games covering different industries. What we have found, is that the highest ranked companies in their respective games deliver the greatest positive price movement for that week. This week the winners include...
UA: 39.90 (+0.29), TSLA: 206.43 (+1.21), BIIB: 314.81 (+2.81), AMZN: 804.70 (+14.96), SPY: 217.18 (+1.36), FB: 130.08 (+0.14), XOM: 83.54 (+0.24), AAPL: 114.62 (+1.07)

Biotech Stock Roundup: CoLucid Soars on Migraine Data, Dynavax Drug FDA Panel Meeting Cancelled
Arpita Dutt - Zacks Investment Research - Wed Sep 07, 8:30AM CDT
Although it was a relatively slow week for the biotech sector, companies like CoLucid (CLCD) and Dynavax were in the news with pipeline updates.
DVAX: 11.62 (-0.05), BIIB: 314.81 (+2.81), CLCD: 31.06 (-2.15), BMRN: 97.45 (-0.12), ALXN: 133.69 (+3.33), AMGN: 175.62 (+1.77), SPPI: 4.81 (+0.34)

Research Reports Coverage on Biotech Stocks -- Biogen, ImmunoGen, Jazz Pharma, and Cempra
PR Newswire - Wed Sep 07, 7:05AM CDT
The Biotech arena took a beating at the start of this year, but recent major takeovers have started drawing investors' interests back toward the industry. Stock-Callers.com shifts investors' attention to these four equities and see if they are positioned for long-term growth: Biogen Inc. (NASDAQ: BIIB), ImmunoGen Inc. (NASDAQ: IMGN), Jazz Pharmaceuticals PLC (NASDAQ: JAZZ), and Cempra Inc. (NASDAQ: CEMP). These stocks research reports can be downloaded now by simply registering for free at:
BIIB: 314.81 (+2.81), JAZZ: 126.65 (-2.16), IMGN: 2.87 (-0.01), CEMP: 24.60 (-0.01)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Skyways Unleashes Skyreach: A Bold Step in Autonomous Cargo

Dropping Cargo the New Way No more messing around with runways and cumbersome logistics—Skyways just took a sledgehammer to traditional cargo transport with the launch of its Skyreach platform. This bad boy is a long-range autonomous Vertical Takeoff and Landing (VTOL) aircraft that promises to shake up the defense and commercial sectors. We've got flights kicking off...

Xinjiang Women Embrace New Horizons in Tianshan Peaks

Scaling New Heights in Xinjiang Up there on the Tianshan Mountains, looking past those towering cliffs, what catches the eye isn't just breathtaking views but rising opportunities. In the land of Xinjiang, far from the bustling metropolises, young women are finding platforms to not just exist but to thrive. City by city, the narrative is changing as these women carve...

AI Faces Accountability Trials in Business 2027

Charting the AI Accountability Course In 2027, the corporate AI landscape won't be the Wild West anymore; it's morphing into a structured battlefield where the winners will be those who successfully enforce accountability. The hands-off, carte blanche days of AI are fading fast, and businesses are starting to scrutinize the AI tools they've been throwing money at. "The...

Strathcona and Greenfire Set Sights on Major Merger

Strathcona's Bold Move for Greenfire: A Game Changer? Just this week, Strathcona Resources Ltd. decided to make a big splash in the oil sands space by proposing to acquire Greenfire Resources Ltd. This isn’t your run-of-the-mill grab—it's a strategic tango expected to shift billions and reshape what we know about Canada’s oil sands territory. Unpicking the Deal...

Korean 'Glocal' Districts Entice U.S. Tourists with Local Flavor

Gwangju's Dongmyeong-dong is like the neighborhood artists and hipsters flock to in New York—except it’s got a Korean twist. Nestled in the Jeonnam region, this place is hot on American tourists' radar for its spicy mix of local culture, unique eats, and shops that scream individuality. It's becoming a magnet for folks who want to get a taste of Korean life but with a...

Inside Kristallnacht: An XR Journey for a New World

Bridging the Past with Powerful Tech: A Journey to Kristallnacht Let's cut to the chase: if there's a time in history that we all need to sear into our collective consciousness, it's Kristallnacht. Forget the mere notion of reading it from a textbook; now you can dive headfirst into the harrowing events of November 9, 1938, thanks to the cutting-edge initiative inside...

Alscan Clinches Three PSA Awards, Sets Industry Standard

Alscan's Triple Trophy Triumph with PSA Network in 2026 Talk about setting the bar high! Alscan snagged not one, not two, but three prestigious awards from the PSA Network—quite a haul for any outfit looking to make waves in the security systems game. The recognition showcases their prowess in custom security solutions, serving businesses and industries with vigilance...

Segway Powersports Ventures into Baja 1000: Ambitions Run High

They're gunning for glory in the sands of Baja, folks—Segway Powersports is about to rev up the excitement with its Baja 1000 debut. Never heard before in this legendary race's chronicles, Segway aims to shake up the game with their two brawny Super Villain UTVs. These aren't your run-of-the-pavement ride-ons; they're built for the rough stuff—and if there's a stage...

Rosti Group Expands with Alvi Acquisition

By Ryan Hughes Updated Nov 9, 2026 Category News Views 139

Rosti Bets on Expansion with Alvi Buyout Rosti Group just rolled the dice big by swallowing Alvi Group, marking another bold move in the ever-swinging industrial and medical device manufacturing rodeo. Suddenly, we’re talking about a company with roughly 3,000 employees on its roster and a neat EUR 450 million in combined revenue. Don't overlook the power play...

Xiaomi's Smart Auto Factory Draws Global Media Praise

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...